Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

BACKGROUND:Existing studies of solid cancers in rheumatoid arthritis (RA) reflect cancer morbidity up until the early 1990s in prevalent cohorts admitted to hospital during the 1980s.OBJECTIVE:To d ...